scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHOPHTHALMOL.2010.19 |
P698 | PubMed publication ID | 20212208 |
P50 | author | Susan E Bronskill | Q89428603 |
P2093 | author name string | Sudeep S Gill | |
Chaim M Bell | |||
Robert J Campbell | |||
J Michael Paterson | |||
Marlo Whitehead | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 359-362 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | JAMA Ophthalmology | Q4787301 |
P1476 | title | Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis | |
P478 | volume | 128 |
Q40644641 | 5-Aminoimidazole-4-carboxamide ribonucleoside-mediated adenosine monophosphate-activated protein kinase activation induces protective innate responses in bacterial endophthalmitis |
Q26995920 | Advances in drug delivery to the posterior segment |
Q36075546 | Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study. |
Q89338057 | Association of Cataract Surgery With Traffic Crashes |
Q58784488 | Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents |
Q46029381 | Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents. |
Q28084070 | Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review |
Q41878765 | Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis |
Q45875451 | Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery |
Q36645753 | Psychological and cognitive determinants of vision function in age-related macular degeneration |
Q36569567 | Temporal retinal transcriptome and systems biology analysis identifies key pathways and hub genes in Staphylococcus aureus endophthalmitis |
Q46526244 | Therapeutic efficacy of bevacizumab for age-related macular degeneration: what are the implications of CATT for routine management? |
Q39261103 | Topical antibiotics and intravitreal injections |
Search more.